Sale!

PARN Gene Dyskeratosis Congenita Autosomal Recessive Type 6 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PARN Gene Dyskeratosis Congenita Autosomal Recessive Type 6 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the PARN gene associated with autosomal recessive dyskeratosis congenita type 6. This advanced next-generation sequencing test provides crucial diagnostic information for patients experiencing bone marrow failure, abnormal skin pigmentation, nail dystrophy, and oral leukoplakia. By detecting specific genetic variants, the test enables accurate diagnosis, facilitates early intervention, and helps guide personalized treatment strategies. The test costs $500 USD and is essential for individuals with family history of bone marrow disorders or those presenting with characteristic symptoms of this rare genetic condition. Results are typically available within 3-4 weeks, providing valuable insights for clinical management and genetic counseling.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PARN Gene Dyskeratosis Congenita Autosomal Recessive Type 6 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Bone Marrow Failure Disorders

The PARN Gene Dyskeratosis Congenita Autosomal Recessive Type 6 NGS Genetic DNA Test represents a cutting-edge diagnostic tool for identifying mutations in the PARN gene, which plays a critical role in maintaining telomere stability and cellular function. This specialized genetic test utilizes next-generation sequencing technology to provide comprehensive analysis of the PARN gene, enabling accurate diagnosis of autosomal recessive dyskeratosis congenita type 6—a rare inherited disorder characterized by bone marrow failure, skin abnormalities, and increased cancer risk.

What This Test Measures and Detects

This advanced genetic test specifically targets and analyzes the PARN (poly(A)-specific ribonuclease) gene, which encodes an enzyme essential for RNA processing and telomere maintenance. The test detects:

  • Pathogenic variants and mutations in the PARN gene
  • Single nucleotide polymorphisms (SNPs) associated with disease
  • Insertions, deletions, and copy number variations
  • Compound heterozygous mutations in autosomal recessive inheritance
  • Genetic markers linked to telomere biology disorders

Who Should Consider This Test

This genetic test is recommended for individuals presenting with symptoms suggestive of dyskeratosis congenita or those with a family history of the condition. Key indications include:

  • Patients with unexplained bone marrow failure or aplastic anemia
  • Individuals displaying characteristic skin abnormalities including reticulate hyperpigmentation
  • Patients with nail dystrophy or abnormal nail growth
  • Individuals with oral leukoplakia (white patches in the mouth)
  • Those with pulmonary fibrosis or early-onset lung disease
  • Patients with increased cancer susceptibility, particularly squamous cell carcinoma
  • Individuals with growth retardation or developmental delays
  • Those with a family history of dyskeratosis congenita or bone marrow failure disorders

Benefits of Genetic Testing

Undergoing the PARN Gene Dyskeratosis Congenita test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out autosomal recessive dyskeratosis congenita type 6
  • Early Intervention: Enables proactive management of bone marrow complications
  • Personalized Treatment: Guides targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Cancer Surveillance: Facilitates appropriate cancer screening protocols
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Advances understanding of telomere biology disorders

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and medical geneticists. Possible outcomes include:

  • Positive Result: Identification of pathogenic mutations confirms diagnosis of autosomal recessive dyskeratosis congenita type 6
  • Negative Result: No disease-causing mutations detected, though clinical follow-up may still be necessary
  • Variant of Uncertain Significance: Genetic changes identified whose clinical significance requires further investigation
  • Carrier Status: Identification of individuals carrying one copy of a mutated gene

All positive results include detailed recommendations for clinical management, surveillance protocols, and family testing considerations.

Test Details and Pricing

Test Component Details
Test Name PARN Gene Dyskeratosis Congenita Autosomal Recessive Type 6 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories and certified genetic counselors ensure you receive the highest quality care and accurate results.

Take the Next Step Toward Genetic Clarity

If you or a family member are experiencing symptoms of dyskeratosis congenita or have concerns about inherited bone marrow disorders, don’t wait to get the answers you need. Our team of genetic specialists is ready to provide comprehensive testing, counseling, and support throughout your diagnostic journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or book your test online. Take control of your genetic health with confidence and clarity.